Short description
VBL Therapeutics is a clinical-stage platform company developing targeted therapies for immune-inflammatory diseases.
Description
VBL Therapeutics is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases.
VBL’s clinical pipeline is based on two distinct, proprietary platform technologies that leverage the body’s natural physiologic and genetic regulatory elements.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Or Yehuda, Tel Aviv, Israel, Asia
Founded on
January 1, 2000
Exited on
October 1, 2014
Went public on
October 1, 2014
Stock symbol
VBLT
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Cannot Access, Cannot Access, Nopepepe, Noaccessforu
Sign in for full access
Founders
Dror Harats